OvaGene Oncology Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
OvaGene Oncology was a privately held biotechnology company based in Irvine, California, focused on developing and commercializing personalized DNA-based diagnostics for gynecologic cancers. Its offerings were intended to support the diagnosis and management of gynecologic oncology conditions for use by healthcare professionals. The company operated with a small team and ceased operations in 2017. In 2014, OvaGene announced a collaboration with HTG Molecular to adopt HTG's diagnostic platform for its gynecologic cancer tests. This partnership shows how the company sought to integrate diagnostic technology within its offerings while operating in the biotechnology research sector.